Characteristics of self-care interventions for patients with a chronic condition: A scoping review.
Riegel B, Westland H, Iovino P, Barelds I, Bruins Slot J, Stawnychy MA, Osokpo O, Tarbi E, Trappenburg JCA, Vellone E, Strömberg A, Jaarsma T.
Int J Nurs Stud. 2021 Apr;116:103713. doi: 10.1016/j.ijnurstu.2020.103713. Epub 2020 Jul 15.
Psychological interventions for coronary heart disease.
Richards SH, Anderson L, Jenkinson CE, Whalley B, Rees K, Davies P, Bennett P, Liu Z, West R, Thompson DR, Taylor RS.
Cochrane Database Syst Rev. 2017 Apr 28;4(4):CD002902. doi: 10.1002/14651858.CD002902.pub4.
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.
Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S; GLOBAL LEADERS Investigators.
Lancet. 2018 Sep 15;392(10151):940-949. doi: 10.1016/S0140-6736(18)31858-0. Epub 2018 Aug 27.
Hemiblocks revisited.
Elizari MV, Acunzo RS, Ferreiro M.
Circulation. 2007 Mar 6;115(9):1154-63. doi: 10.1161/CIRCULATIONAHA.106.637389.
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, Batushkin V, Campo G, Lysak Z, Vakaliuk I, Milewski K, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Goette A.
Lancet. 2019 Oct 12;394(10206):1335-1343. doi: 10.1016/S0140-6736(19)31872-0. Epub 2019 Sep 3.
Polyvascular Disease in the Gulf Region: Concealed Marker of Poor Outcomes in Acute Coronary Syndrome.
Syed A, Hashmani S, Darr U, Bhatnagar G, Tuzcu EM, Hasan F.
Curr Probl Cardiol. 2022 Dec;47(12):101357. doi: 10.1016/j.cpcardiol.2022.101357. Epub 2022 Aug 20.
Psychological interventions for coronary heart disease.
Rees K, Bennett P, West R, Davey SG, Ebrahim S.
Cochrane Database Syst Rev. 2004;(2):CD002902. doi: 10.1002/14651858.CD002902.pub2.
Internet-based interventions for the secondary prevention of coronary heart disease.
Devi R, Singh SJ, Powell J, Fulton EA, Igbinedion E, Rees K.
Cochrane Database Syst Rev. 2015 Dec 22;2015(12):CD009386. doi: 10.1002/14651858.CD009386.pub2.
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M, Palmer SC, Natale P, Craig JC, Vecchio M, Elder GJ, Strippoli GF.
Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3.
Common genetic risk factors for coronary artery disease: new opportunities for prevention?
Hamrefors V.
Clin Physiol Funct Imaging. 2017 May;37(3):243-254. doi: 10.1111/cpf.12289. Epub 2015 Aug 17.
